Dr. John Paul Waymack – MD, ScD
Founder, Chief Medical Officer
Dr. Waymack has served as CMO since July 2013. Dr. Waymack brings to Kitov over 20 years' experience in the biopharma field. A former academic transplant surgeon and FDA medical officer, he has over 20 years' experience as a drug development consultant for major pharmaceutical companies, including Pfizer, Roche, Pharmacia, Warner Lambert and Searle. During his 10-year academic career, Dr. Waymack published over 100 scientific essays, mainly in the fields of prostaglandins and immunology. In addition, he was commissioned and served as a Major in the US Army Medical Corps in the position of Chief of Surgical Research at the Institute for Surgical Research. Dr. Waymack was also an Associate Professor of Surgery at the University of Texas Medical Branch and at the University of Medicine and Dentistry of New Jersey.
Chief Executive Officer
Mr. Israel has served as CEO since October 2012. Prior to joining Kitov, Mr. Israel served as Vice President - Business Development at Capital Point (TASE: CPTP). Before that, Mr. Israel was the founding CEO of Uneri Capital, a consulting firm in the capital markets field specializing in the healthcare sector, from 2008 until 2011. Prior to that, Mr. Israel was the founding CEO of BeeContact (formerly TASE: BCNT), from 2001 until 2007. Mr. Israel also serves as the Chairman of the Board of NextGen BioMed (TASE: NXGN), and as a board member for various private healthcare corporations.
Simcha Rock – CPA, MBA
Chief Financial Officer
Mr. Rock has served as CFO since July 2013. Prior to joining Kitov, Mr. Rock was a private equity manager at Edmond de Rothschild Private Equity Management, a firm specializing in the management of venture capital and other private equity investment funds, from 2000 until 2011. In that capacity, he was responsible for all financial, legal and administrative matters for several investment funds. Before that, Mr. Rock held financial management positions at Intel Electronics, The Jerusalem College of Technology, and JC Technologies.
Dr. William Berlin – PhD
Manager of Chemistry, Manufacturing and Control
Dr. Berlin has been providing Kitov with consulting services in the areas of Chemistry, Manufacturing and Control since July 2013.
Dr. Berlin is a former FDA chemist with over 15 years experience in drug development and consulting for multinational and emerging biotech and pharma companies.
Dr. Gil Ben-Menachem – MSc, MBA, PhD
Vice President - Business Development
Dr. Ben-Menachem has over 15 years experience in the pharmaceutical, biotechnology and venture capital industries. Before joining Kitov, Dr. Ben-Menachem was Head of Innovative Products at Dexcel Pharma. Prior to that, he was CEO of OphthaliX and Director of Business Development at Teva Pharmaceutical Industries, where he was responsible for business development efforts leading to partnership and acquisition deals valued at over $500 million for late-stage innovative drug candidates. Before that, he served as Director of Business Development at Paramount Biosciences, a New York-based merchant bank and biotechnology venture capital firm.
Avraham Ben-Tzvi - Adv.
General Counsel and Company Secretary.
Adv. Ben-Tzvi has over 20 years professional experience in various legal, corporate finance, banking and business development roles. He previously served as general counsel and company secretary at Medigus Ltd., an Israeli medical device company listed on NASDAQ and the TASE. Prior to that he served as an attorney at Yigal Arnon & Co. where, among other corporate and commercial work, he advised companies and underwriters on various offerings by Israeli companies listing in the U.S. and/or on TASE and on various SEC and Israeli related securities law filings. Mr. Ben-Tzvi holds a BA with honors in Economics from Yeshiva University in New York and an LLB with honors from The School of Law at the Sha'arei Mishpat Academic Center of Law and Sience in Israel, and has been a member of the Israeli Bar Association since 2009.